MCL-Pharma

MCL-Pharma is a Russian pharmaceutical company based in Moscow that focuses on the development, clinical evaluation, and commercialization of respiratory and antiviral therapies. The company is notable for sponsoring clinical trials evaluating the efficacy and safety of Cineole (Soledum) as an add-on therapy to standard antiviral treatments (such as Ingavirin) for acute bronchitis and tracheobronchitis. Its research has demonstrated that the addition of Cineole significantly reduces cough frequency, dyspnea, and chest pain, thereby accelerating patient recovery. MCL-Pharma operates primarily within the Russian Federation and Eastern European markets, targeting common cold manifestations and respiratory tract infections.